???global.info.a_carregar???
Edward Tate.
Identificação

Identificação pessoal

Nome completo
Edward Tate

Nomes de citação

  • Tate, Edward W.

Identificadores de autor

Ciência ID
7119-65B8-3D3A
ORCID iD
0000-0003-2213-5814
Formação
Grau Classificação
2000
Concluído
Organic Chemistry (Doktor (PhD))
University of Cambridge, Reino Unido
1996
Concluído
Chemistry (Bachelor)
Especialização em Chemistry
Durham University, Reino Unido
1st Class Honours
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento
Empregador
2006 - 2011 Investigador principal (carreira) (Investigação) Imperial College London, Reino Unido
Imperial College London, Reino Unido
2004 - 2006 Investigador (Investigação) Imperial College London, Reino Unido
Imperial College London, Reino Unido
2002 - 2003 Pós-doutorado (Investigação) Institut Pasteur, França
Institut Pasteur, França
2000 - 2002 Investigador (Investigação) Ecole Polytechnique, Paris, France, França
Ecole Polytechnique, Paris, France, França

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento
Empregador
2014 - Atual Professor Associado (Docente Universitário) Imperial College London, Reino Unido
Imperial College London, Reino Unido

Cargos e Funções

Categoria Profissional
Instituição de acolhimento
Empregador
2019 - Atual Presidente do Conselho Científico Myricx Pharma Ltd, Reino Unido
Myricx Pharma Ltd, Reino Unido
2017 - Atual Presidente de Unidade Orgânica The Francis Crick Institute, Reino Unido
The Francis Crick Institute, Reino Unido
2009 - 2016 Chemical Genetics Research Theme Leader, British Heart Foundation Centre of Excellence British Heart Foundation Centre of Excellence, Reino Unido
2012 - 2014 Reader in Chemical Biology Imperial College London, Reino Unido
Imperial College London, Reino Unido
2010 - 2012 Senior Lecturer in Chemical Biology Imperial College London, Reino Unido
Imperial College London, Reino Unido

Outros

Categoria Profissional
Instituição de acolhimento
Empregador
2017 - Atual Director of the Imperial Centre for Drug Discovery Science (CDDS) Imperial College London, Reino Unido
2011 - Atual Director, MRes in Drug Discovery and Development xxxx, Reino Unido
Projetos

Bolsa

Designação Financiadores
2002 - 2003 Howard Trust Research Fellow
xxxx
Bolseiro de Pós-Doutoramento
Concluído
2000 - 2002 Royal Exhibition of 1851 Research Fellow
xxxx
Investigador
Ecole Polytechnique, Paris, France, França
Concluído

Outro

Designação Financiadores
2020/10 - 2024/09 Synthetic lethality driven by N-myristoyltransferase inhibition
xxxx
Investigador responsável
Cancer Research UK
2019/10 - 2024/09 Synthetic Chemistry and Chemical Biology Lab
xxxx
Investigador
2020/10 - 2023/09 Hedgehog acyltransferase: structure and function in health and disease
xxxx
Investigador responsável
Biotechnology and Biological Sciences Research Council
2018/10 - 2022/09 Targeting dynamic protein S-acylation in metastatic cancer
xxxx
Investigador responsável
Cancer Research UK
2018/10 - 2022/09 Targeting the membrane attack complex to enhance cancer immunotherapy
xxxx
Investigador responsável
Cancer Research UK
2019/05 - 2022/07 A chemical proteomic platform to uncover the impact of dynamic protein S-acylation in cancer
xxxx
Cancer Research UK
Em curso
2020/07 - 2022/06 Targeting Rab27 in metastatic cancer
xxxx
Investigador responsável
Horizon 2020
2019/04 - 2022/03 Unlocking the KLK activome in drug-resistant cancer: biomarker discovery & target validation
xxxx
Worldwide Cancer Research
2020/04 - 2021/12 Prenylation dynamics in cancer
xxxx
Investigador responsável
Kura Oncology Inc
2018/10 - 2021/12 Programming GPCR signalling within the endocytic network; mechanisms and therapeutic applications
xxxx
Investigador
Biotechnology and Biological Sciences Research Council
2017/10 - 2021/09 Novel multifunctional PROTACs
xxxx
Investigador responsável
2017/10 - 2021/09 KLK Proteases: biomarkers and therapeutic targets in ovarian and pancreatic cancer
xxxx
Investigador responsável
Cancer Research UK
2015/10 - 2021/09 Protein Lipidation in Cancer: scope, dysfunction and potential for therapeutic intervention
xxxx
Investigador responsável
Cancer Research UK
2020/04 - 2021/08 Accelerating anticancer drug development
xxxx
Investigador responsável
2019/09 - 2021/08 SIPCA, Synthesis and validation of chemical Probes for Centrosome Declustering
xxxx
Investigador responsável
Horizon 2020
2020/01 - 2021/06 Core equipment grant (flow cytometry)
xxxx
Investigador
2019/11 - 2021/06 DRUG DISCOVERY AND DEVELOPMENT
xxxx
Investigador responsável
2019/07 - 2021/06 TargetDUBs, Targeting ubiquitin processing in cancer and fibrosis: novel probes for the UCHLs
xxxx
Investigador responsável
2018/12 - 2021/06 Development of cell-permeable activity-based probes for deubiquitinases
xxxx
Investigador responsável
Pfizer Inc
2016/01 - 2021/03 Drug Discovery Award: Rab27a: a novel drug target in cancer
xxxx
Investigador responsável
Cancer Research UK
2020/01 - 2020/12 Convergence platform for rapid cell-type specific target deconvolution
xxxx
Investigador responsável
2020/01 - 2020/12 Targeting USP30 in cancer: probes for target validation
xxxx
Investigador responsável
2019/01 - 2020/12 Protein lipidation in inflammation
xxxx
Investigador responsável
Em curso
2018/11 - 2020/10 Novel multifunctional PROTACs
xxxx
Investigador responsável
2017/10 - 2020/10 5 confidence-in-concept awards, drug discovery
xxxx
Investigador responsável
2016/10 - 2020/09 Chemical proteomic technologies targeting protein modification in cancer
xxxx
Investigador
2016/07 - 2020/08 Short chain fatty acids and gut hormone release
xxxx
Investigador
Biotechnology and Biological Sciences Research Council
Em curso
2016/07 - 2020/08 Interplay between fermentable carbohydrate, short chain fatty acids and gut hormone release
xxxx
Investigador
Biotechnology and Biological Sciences Research Council
2018/08 - 2020/07 TNFaLysMyr, Protein lipidation in inflammation
xxxx
Investigador responsável
2019/07 - 2020/06 A surface plasmon resonance facility for label-free analysis of biomolecular interactions
xxxx
Investigador
Biotechnology and Biological Sciences Research Council
2016/07 - 2020/06 18ALERT: Surface plasmon resonance facility
xxxx
Investigador responsável
Biotechnology and Biological Sciences Research Council
2016/05 - 2020/06 Analysis of rhinovirus replication complexes
xxxx
Investigador
Asthma UK
2020/01 - 2020 Novel immunomodulatory ligands for CD59
xxxx
Investigador responsável
2010/01 - 2018/06 Development of Antimalarial NMT inhibitors
xxx
Investigador responsável
MRC&MMV
Concluído
2006 - 2011 BBSRC David Phillips Research Fellowship
xxxx
Investigador responsável
Imperial College London, Reino Unido
Produções

Publicações

Artigo em revista
  1. Matthew E.H. White; Jesús Gil; Edward W. Tate. "Proteome-wide structural analysis identifies warhead- and coverage-specific biases in cysteine-focused chemoproteomics". Cell Chemical Biology (2023): https://doi.org/10.1016/j.chembiol.2023.06.021.
    10.1016/j.chembiol.2023.06.021
  2. Elizabeth V. K. Ledger; Katie Lau; Edward W. Tate; Andrew M. Edwards. "XerC Is Required for the Repair of Antibiotic- and Immune-Mediated DNA Damage in Staphylococcus aureus". Antimicrobial Agents and Chemotherapy (2023): https://doi.org/10.1128/aac.01206-22.
    10.1128/aac.01206-22
  3. Emma C. Couves; Scott Gardner; Tomas B. Voisin; Jasmine K. Bickel; Phillip J. Stansfeld; Edward W. Tate; Doryen Bubeck. "Structural basis for membrane attack complex inhibition by CD59". Nature Communications (2023): https://doi.org/10.1038/s41467-023-36441-z.
    10.1038/s41467-023-36441-z
  4. Roman O. Fedoryshchak; Andrii Gorelik; Mengjie Shen; Maria M. Shchepinova; Inmaculada Pérez-Dorado; Edward W. Tate. "Discovery of lipid-mediated protein–protein interactions in living cells using metabolic labeling with photoactivatable clickable probes". Chemical Science (2023): https://doi.org/10.1039/D2SC06116C.
    10.1039/D2SC06116C
  5. Milon Mondal; Daniel Conole; Jaya Nautiyal; Edward W. Tate. "UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology". British Journal of Cancer (2022): https://doi.org/10.1038/s41416-021-01516-5.
    10.1038/s41416-021-01516-5
  6. Wouter W. Kallemeijn; Thomas Lanyon-Hogg; Nattawadee Panyain; Andrea Goya Grocin; Paulina Ciepla; Julia Morales-Sanfrutos; Edward W. Tate. "Proteome-wide analysis of protein lipidation using chemical probes: in-gel fluorescence visualization, identification and quantification of N-myristoylation, N- and S-acylation, O-cholesterylation, S-farnesylation and S-geranylgeranylation". Nature Protocols (2021): https://doi.org/10.1038/s41596-021-00601-6.
    10.1038/s41596-021-00601-6
  7. Andrea Goya Grocin; Wouter W. Kallemeijn; Edward W. Tate. "Targeting methionine aminopeptidase 2 in cancer, obesity, and autoimmunity". Trends in Pharmacological Sciences (2021): https://doi.org/10.1016/j.tips.2021.07.004.
    10.1016/j.tips.2021.07.004
  8. Elena De Vita; Daniel Lucy; Edward W. Tate. "Beyond targeted protein degradation: LD·ATTECs clear cellular lipid droplets". Cell Research (2021): https://doi.org/10.1038/s41422-021-00546-1.
    10.1038/s41422-021-00546-1
  9. Cassandra R. Kennedy; Andrea Goya Grocin; Tristan Kovacic; Ravi Singh; Jennifer A. Ward; Avinash R. Shenoy; Edward W. Tate. "A Probe for NLRP3 Inflammasome Inhibitor MCC950 Identifies Carbonic Anhydrase 2 as a Novel Target". ACS Chemical Biology (2021): https://doi.org/10.1021/acschembio.1c00218.
    10.1021/acschembio.1c00218
  10. Benns, H.J.; Wincott, C.J.; Tate, E.W.; Child, M.A.. "Activity- and reactivity-based proteomics: Recent technological advances and applications in drug discovery". Current Opinion in Chemical Biology 60 (2021): 20-29. http://www.scopus.com/inward/record.url?eid=2-s2.0-85088930497&partnerID=MN8TOARS.
    10.1016/j.cbpa.2020.06.011
  11. Losada de la Lastra, A.; Hassan, S.; Tate, E.W.. "Deconvoluting the biology and druggability of protein lipidation using chemical proteomics". Current Opinion in Chemical Biology 60 (2021): 97-112. http://www.scopus.com/inward/record.url?eid=2-s2.0-85096507708&partnerID=MN8TOARS.
    10.1016/j.cbpa.2020.10.002
  12. Nattawadee Panyain; Aurélien Godinat; Aditya Raymond Thawani; Sofía Lachiondo-Ortega; Katie Mason; Sarah Elkhalifa; Lisa M. Smith; Jeanine A. Harrigan; Edward W. Tate. "Activity-based protein profiling reveals deubiquitinase and aldehyde dehydrogenase targets of a cyanopyrrolidine probe". RSC Medicinal Chemistry (2021): https://doi.org/10.1039/D1MD00218J.
    10.1039/D1MD00218J
  13. Cyrille S. Kounde; Edward W. Tate. "Photoactive Bifunctional Degraders: Precision Tools To Regulate Protein Stability". Journal of Medicinal Chemistry (2020): https://doi.org/10.1021/acs.jmedchem.0c01542.
    10.1021/acs.jmedchem.0c01542
  14. Cyril Dian; Inmaculada Pérez-Dorado; Frédéric Rivière; Thomas Asensio; Pierre Legrand; Markus Ritzefeld; Mengjie Shen; et al. "High-resolution snapshots of human N-myristoyltransferase in action illuminate a mechanism promoting N-terminal Lys and Gly myristoylation". Nature Communications (2020): https://doi.org/10.1038/s41467-020-14847-3.
    10.1038/s41467-020-14847-3
  15. Elena De Vita; Maria Maneiro; Edward W. Tate. "The Missing Link between (Un)druggable and Degradable KRAS". ACS Central Science (2020): https://doi.org/10.1021/acscentsci.0c00920.
    10.1021/acscentsci.0c00920
  16. Mari´a Maneiro; Nafsika Forte; Maria M. Shchepinova; Cyrille S. Kounde; Vijay Chudasama; James Richard Baker; Edward W. Tate. "Antibody–PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4". ACS Chemical Biology (2020): https://doi.org/10.1021/acschembio.0c00285.
    10.1021/acschembio.0c00285
  17. Charlie N. Saunders; Ernesto Cota; Jake Baum; Edward W. Tate. "Peptide Probes for Plasmodium falciparum MyoA Tail Interacting Protein (MTIP): Exploring the Druggability of the Malaria Parasite Motor Complex". ACS Chemical Biology (2020): https://doi.org/10.1021/acschembio.0c00328.
    10.1021/acschembio.0c00328
  18. Camilla TO Benfield; Farrell MacKenzie; Markus Ritzefeld; Michela Mazzon; Stuart Weston; Edward W Tate; Boon Han Teo; et al. "Correction: Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domain". Life Science Alliance (2020): https://doi.org/10.26508/lsa.202000747.
    10.26508/lsa.202000747
  19. Daniel Paolo Anderson; Henry James Benns; Edward William Tate; Matthew Andrew Child. "CRISPR - TAPE : protein-centric CRISPR guide design for targeted proteome engineering". Molecular Systems Biology 16 6 (2020): https://doi.org/10.15252/msb.20209475.
    10.15252/msb.20209475
  20. Jennifer A. Ward; Adan Pinto-Fernandez; Loïc Cornelissen; Sarah Bonham; Laura Díaz-Sáez; Olivier Riant; Kilian V. M. Huber; et al. "Re-Evaluating the Mechanism of Action of a,ß-Unsaturated Carbonyl DUB Inhibitors b-AP15 and VLX1570: A Paradigmatic Example of Unspecific Protein Cross-linking with Michael Acceptor Motif-Containing Drugs". Journal of Medicinal Chemistry (2020): https://doi.org/10.1021/acs.jmedchem.0c00144.
    10.1021/acs.jmedchem.0c00144
  21. Cesira de Chiara; Miha Homšak; Gareth A. Prosser; Holly L. Douglas; Acely Garza-Garcia; Geoff Kelly; Andrew G. Purkiss; Edward W. Tate; Luiz Pedro S. de Carvalho. "d-Cycloserine destruction by alanine racemase and the limit of irreversible inhibition". Nature Chemical Biology (2020): https://doi.org/10.1038/s41589-020-0498-9.
    10.1038/s41589-020-0498-9
  22. Ainoa Rueda-Zubiaurre; Sabrina Yahiya; Oliver J. Fischer; Xiaojun Hu; Charlie N. Saunders; Sachi Sharma; Ursula Straschil; et al. "Structure–Activity Relationship Studies of a Novel Class of Transmission Blocking Antimalarials Targeting Male Gametes". Journal of Medicinal Chemistry 63 5 (2020): 2240-2262. https://doi.org/10.1021/acs.jmedchem.9b00898.
    10.1021/acs.jmedchem.9b00898
  23. Ryan T. Howard; Paul Hemsley; Philip Petteruti; Charlie N. Saunders; Javier A. Molina Bermejo; James S. Scott; Jeffrey W. Johannes; Edward W. Tate. "Structure-Guided Design and In-Cell Target Profiling of a Cell-Active Target Engagement Probe for PARP Inhibitors". ACS Chemical Biology (2020): https://doi.org/10.1021/acschembio.9b00963.
    10.1021/acschembio.9b00963
  24. Camilla TO Benfield; Farrell MacKenzie; Markus Ritzefeld; Michela Mazzon; Stuart Weston; Edward Tate; Boon Han Teo; et al. "Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domain". Life Science Alliance (2020): https://doi.org/10.26508/lsa.201900542.
    10.26508/lsa.201900542
  25. Roman O. Fedoryshchak; Cory A. Ocasio; Benjamin Strutton; Jo Mattocks; Andrew J. Corran; Edward W. Tate. "Wheat pathogen Zymoseptoria tritici N-myristoyltransferase inhibitors: on-target antifungal activity and an unusual metabolic defense mechanism". RSC Chemical Biology 1 2 (2020): 68-78. https://doi.org/10.1039/D0CB00020E.
    10.1039/D0CB00020E
  26. Simões, B.M.; Santiago-Gómez, A.; Chiodo, C.; Moreira, T.; Conole, D.; Lovell, S.; Alferez, D.; et al. "Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer". Oncogene 39 25 (2020): 4896-4908. http://www.scopus.com/inward/record.url?eid=2-s2.0-85085550265&partnerID=MN8TOARS.
    10.1038/s41388-020-1335-z
  27. Caengprasath, N.; Gonzalez-Abuin, N.; Shchepinova, M.; Ma, Y.; Inoue, A.; Tate, E.W.; Frost, G.; Hanyaloglu, A.C.. "Internalization-Dependent Free Fatty Acid Receptor 2 Signaling Is Essential for Propionate-Induced Anorectic Gut Hormone Release". iScience 23 9 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85089812008&partnerID=MN8TOARS.
    10.1016/j.isci.2020.101449
  28. Shchepinova, M.M.; Hanyaloglu, A.C.; Frost, G.S.; Tate, E.W.. "Chemical biology of noncanonical G protein–coupled receptor signaling: Toward advanced therapeutics". Current Opinion in Chemical Biology 56 (2020): 98-110. http://www.scopus.com/inward/record.url?eid=2-s2.0-85084798474&partnerID=MN8TOARS.
    10.1016/j.cbpa.2020.04.012
  29. Panyain, N.; Godinat, A.; Lanyon-Hogg, T.; Lachiondo-Ortega, S.; Will, E.J.; Soudy, C.; Mondal, M.; et al. "Discovery of a Potent and Selective Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with Antifibrotic Activity". Journal of the American Chemical Society 142 28 (2020): 12020-12026. http://www.scopus.com/inward/record.url?eid=2-s2.0-85088178239&partnerID=MN8TOARS.
    10.1021/jacs.0c04527
  30. Shackley, M.; Ma, Y.; Tate, E.W.; Brown, A.J.H.; Frost, G.; Hanyaloglu, A.C.. "Short Chain Fatty Acids Enhance Expression and Activity of the Umami Taste Receptor in Enteroendocrine Cells via a Gai/o Pathway". Frontiers in Nutrition 7 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85095996386&partnerID=MN8TOARS.
    10.3389/fnut.2020.568991
  31. Fang, Z.; Chen, S.; Manchanda, Y.; Bitsi, S.; Pickford, P.; David, A.; Shchepinova, M.M.; et al. "Ligand-specific factors influencing glp-1 receptor post-endocytic trafficking and degradation in pancreatic beta cells". International Journal of Molecular Sciences 21 21 (2020): 1-24. http://www.scopus.com/inward/record.url?eid=2-s2.0-85095842302&partnerID=MN8TOARS.
    10.3390/ijms21218404
  32. Bell, A.S.; Yu, Z.; Hutton, J.A.; Wright, M.H.; Brannigan, J.A.; Paape, D.; Roberts, S.M.; et al. "Novel Thienopyrimidine Inhibitors of Leishmania N-Myristoyltransferase with On-Target Activity in Intracellular Amastigotes". Journal of Medicinal Chemistry 63 14 (2020): 7740-7765. http://www.scopus.com/inward/record.url?eid=2-s2.0-85088488413&partnerID=MN8TOARS.
    10.1021/acs.jmedchem.0c00570
  33. Barry, R.; Ruano-Gallego, D.; Radhakrishnan, S.T.; Lovell, S.; Yu, L.; Kotik, O.; Glegola-Madejska, I.; et al. "Faecal neutrophil elastase-antiprotease balance reflects colitis severity". Mucosal Immunology 13 2 (2020): 322-333. http://www.scopus.com/inward/record.url?eid=2-s2.0-85076225917&partnerID=MN8TOARS.
    10.1038/s41385-019-0235-4
  34. Kryza, T.; Bock, N.; Lovell, S.; Rockstroh, A.; Lehman, M.L.; Lesner, A.; Panchadsaram, J.; et al. "The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer". Molecular Oncology 14 1 (2020): 105-128. http://www.scopus.com/inward/record.url?eid=2-s2.0-85075748816&partnerID=MN8TOARS.
    10.1002/1878-0261.12587
  35. Broncel, M.; Dominicus, C.; Vigetti, L.; Nofal, S.D.; Bartlett, E.J.; Touquet, B.; Hunt, A.; et al. "Profiling of myristoylation in toxoplasma gondii reveals an n-myristoylated protein important for host cell penetration". eLife 9 (2020): 1-38. http://www.scopus.com/inward/record.url?eid=2-s2.0-85088492475&partnerID=MN8TOARS.
    10.7554/eLife.57861
  36. Tzakoniati, F.; Xu, H.; Li, T.; Garcia, N.; Kugel, C.; Payandeh, J.; Koth, C.M.; Tate, E.W.. "Development of Photocrosslinking Probes Based on Huwentoxin-IV to Map the Site of Interaction on Nav1.7". Cell Chemical Biology 27 3 (2020): 306-313.e4. http://www.scopus.com/inward/record.url?eid=2-s2.0-85081317633&partnerID=MN8TOARS.
    10.1016/j.chembiol.2019.10.011
  37. Lucy, D.; Zhang, L.; Tate, E.W.. "A Natural Product Puts Malaria on a Low-Fat Diet". Cell Chemical Biology 27 2 (2020): 137-139. http://www.scopus.com/inward/record.url?eid=2-s2.0-85079345148&partnerID=MN8TOARS.
    10.1016/j.chembiol.2020.02.001
  38. Panyain, N.; Godinat, A.; Lanyon-Hogg, T.; Lachiondo-Ortega, S.; Will, E.J.; Soudy, C.; Mondal, M.; et al. "Erratum: Discovery of a potent and selective covalent inhibitor and activity-based probe for the deubiquitylating enzyme UCHL1, with antifibrotic activity (Journal of the American Chemical Society (2020) 142:28 (12020-12026) DOI: 10.1021/jacs.0c04527)". Journal of the American Chemical Society 142 35 (2020): 15199-15199. http://www.scopus.com/inward/record.url?eid=2-s2.0-85090250627&partnerID=MN8TOARS.
    10.1021/jacs.0c08385
  39. Kounde, C.S.; Shchepinova, M.M.; Saunders, C.N.; Muelbaier, M.; Rackham, M.D.; Harling, J.D.; Tate, E.W.; et al. "A caged E3 ligase ligand for PROTAC-mediated protein degradation with light". Chemical Communications 56 41 (2020): 5532-5535. http://www.scopus.com/inward/record.url?eid=2-s2.0-85085264012&partnerID=MN8TOARS.
    10.1039/d0cc00523a
  40. Tate, Edward W.. "Validation and Invalidation of Chemical Probes for the Human N-myristoyltransferases.". Cell chemical biology (2019): https://doi.org/10.1016/j.chembiol.2019.03.006.
    10.1016/j.chembiol.2019.03.006
  41. Tate, Edward W.. "Dual chemical probes enable quantitative system-wide analysis of protein prenylation and prenylation dynamics.". Nature chemistry (2019): https://doi.org/10.1038/s41557-019-0237-6.
    10.1038/s41557-019-0237-6
  42. Schlott AC; Mayclin S; Reers AR; Coburn-Flynn O; Bell AS; Green J; Knuepfer E; et al. "Structure-Guided Identification of Resistance Breaking Antimalarial N-Myristoyltransferase Inhibitors.". Cell chemical biology (2019): http://europepmc.org/abstract/med/31080074.
    10.1016/j.chembiol.2019.03.015
  43. Jamshidiha M; Pérez-Dorado I; Murray JW; Tate EW; Cota E; Read RJ. "Coping with strong translational noncrystallographic symmetry and extreme anisotropy in molecular replacement with Phaser: human Rab27a.". Acta crystallographica. Section D, Structural biology (2019): http://europepmc.org/abstract/med/30950405.
    10.1107/S2059798318017825
  44. Tapodi A; Clemens DM; Uwineza A; Goldberg MW; Thinon E; Heal WP; Tate EW; et al. "BFSP1 C-terminal domains released by post-translational processing events can alter significantly the calcium regulation of AQP0 water permeability.". Experimental eye research (2019): http://europepmc.org/abstract/med/30790544.
    10.1016/j.exer.2019.02.001
  45. Andrea Goya Grocin; Remigiusz A. Serwa; Julia Morales Sanfrutos; Markus Ritzefeld; Edward W. Tate; Tate, Edward W.. "Whole Proteome Profiling of N-Myristoyltransferase Activity and Inhibition Using Sortase A". Molecular & Cellular Proteomics 18 1 (2019): 115-126. https://doi.org/10.1074/mcp.RA118.001043.
    10.1074/mcp.RA118.001043
  46. Hong WD; Benayoud F; Nixon GL; Ford L; Johnston KL; Clare RH; Cassidy A; et al. "AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis.". Proceedings of the National Academy of Sciences of the United States of America (2019): http://europepmc.org/abstract/med/30617067.
    10.1073/pnas.1816585116
  47. Benns HJ; Tate EW; Child MA. "Activity-Based Protein Profiling for the Study of Parasite Biology.". Current topics in microbiology and immunology (2019): http://europepmc.org/abstract/med/30105424.
    10.1007/82_2018_123
  48. McCluskey, S.P.; Haslop, A.; Coello, C.; Gunn, R.N.; Tate, E.W.; Southworth, R.; Plisson, C.; Long, N.J.; Wells, L.A.. "Imaging of chemotherapy-induced acute cardiotoxicity with 18F-labeled lipophilic cations". Journal of Nuclear Medicine 60 12 (2019): 1750-1756. http://www.scopus.com/inward/record.url?eid=2-s2.0-85075961456&partnerID=MN8TOARS.
    10.2967/jnumed.119.226787
  49. Serwa, R.A.; Sekine, E.; Brown, J.; Teo, S.H.C.; Tate, E.W.; O’Hare, P.. "Analysis of a fully infectious bio-orthogonally modified human virus reveals novel features of virus cell entry". PLoS Pathogens 15 10 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85073578580&partnerID=MN8TOARS.
    10.1371/journal.ppat.1007956
  50. Doll, S.; Freitas, F.P.; Shah, R.; Aldrovandi, M.; da Silva, M.C.; Ingold, I.; Grocin, A.G.; et al. "FSP1 is a glutathione-independent ferroptosis suppressor". Nature 575 7784 (2019): 693-698. http://www.scopus.com/inward/record.url?eid=2-s2.0-85074985624&partnerID=MN8TOARS.
    10.1038/s41586-019-1707-0
  51. Birtley, J.R.; Alomary, M.; Zanini, E.; Antony, J.; Maben, Z.; Weaver, G.C.; Von Arx, C.; et al. "Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions". Nature Communications 10 1 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85069512251&partnerID=MN8TOARS.
    10.1038/s41467-019-10966-8
  52. Lanyon-Hogg, T.; Ritzefeld, M.; Sefer, L.; Bickel, J.K.; Rudolf, A.F.; Panyain, N.; Bineva-Todd, G.; et al. "Acylation-coupled lipophilic induction of polarisation (Acyl-cLIP): A universal assay for lipid transferase and hydrolase enzymes". Chemical Science 10 39 (2019): 8995-9000. http://www.scopus.com/inward/record.url?eid=2-s2.0-85073415358&partnerID=MN8TOARS.
    10.1039/c9sc01785b
  53. Beard, R.; Gaboriau, D.C.A.; Gee, A.D.; Tate, E.W.; Rhiannon Beard; David C. A. Gaboriau; Antony D. Gee; Edward W. Tate. "Chemical biology tools for probing transcytosis at the blood-brain barrier". Chemical Science 10 46 (2019): 10772-10778. http://www.scopus.com/inward/record.url?eid=2-s2.0-85075720425&partnerID=MN8TOARS.
    10.1039/c9sc04024b
  54. Lim, C.S.Q.; Ha, K.P.; Clarke, R.S.; Gavin, L.-A.; Cook, D.T.; Hutton, J.A.; Sutherell, C.L.; et al. "Identification of a potent small-molecule inhibitor of bacterial DNA repair that potentiates quinolone antibiotic activity in methicillin-resistant Staphylococcus aureus". Bioorganic and Medicinal Chemistry 27 20 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85068790400&partnerID=MN8TOARS.
    10.1016/j.bmc.2019.06.025
  55. Conole, D.; Mondal, M.; Majmudar, J.D.; Tate, E.W.. "Recent Developments in Cell Permeable Deubiquitinating Enzyme Activity-Based Probes". Frontiers in Chemistry 7 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85077329334&partnerID=MN8TOARS.
    10.3389/fchem.2019.00876
  56. Kaiser N; Mejuch T; Fedoryshchak R; Janning P; Tate EW; Waldmann H. "Photoactivatable Myristic Acid Probes for UNC119-Cargo Interactions.". Chembiochem : a European journal of chemical biology (2018): http://europepmc.org/abstract/med/30129686.
    10.1002/cbic.201800406
  57. Wang Z; Grosskurth SE; Cheung T; Petteruti P; Zhang J; Wang X; Wang W; et al. "Pharmacological inhibition of PARP6 triggers multipolar spindle formation and elicits therapeutic effects in breast cancer.". Cancer research 78 23 (2018): 6691-6702. http://europepmc.org/abstract/med/30297535.
    10.1158/0008-5472.can-18-1362
  58. De Vita E; Schüler P; Lovell S; Lohbeck J; Kullmann S; Rabinovich E; Sananes A; et al. "Depsipeptides Featuring a Neutral P1 Are Potent Inhibitors of Kallikrein-Related Peptidase 6 with On-Target Cellular Activity.". Journal of medicinal chemistry (2018): http://europepmc.org/abstract/med/30212625.
    10.1021/acs.jmedchem.8b01106
  59. Furniss RCD; Low WW; Mavridou DAI; Dagley LF; Webb AI; Tate EW; Clements A. "Plasma membrane profiling during enterohemorrhagic E. coli infection reveals that the metalloprotease StcE cleaves CD55 from host epithelial surfaces.". The Journal of biological chemistry (2018): http://europepmc.org/abstract/med/30190327.
    10.1074/jbc.RA118.005114
  60. Gregory B. Craven; Dominic P. Affron; Charlotte E. Allen; Stefan Matthies; Joe G. Greener; Rhodri M. L. Morgan; Edward W. Tate; Alan Armstrong; David J. Mann. "High-Throughput Kinetic Analysis for Target-Directed Covalent Ligand Discovery". Angewandte Chemie International Edition 57 19 (2018): 5257-5261. https://doi.org/10.1002/anie.201711825.
    10.1002/anie.201711825
  61. Alzahofi N; Robinson CL; Welz T; Page EL; Briggs DA; Stainthorp AK; Reekes J; et al. "Rab27a co-ordinates actin-dependent transport by controlling organelle-associated motors and track assembly proteins.". Nature Communications 11 1 (2018): http://europepmc.org/abstract/PPR/PPR13489.
    10.1101/314153
  62. Mousnier A; Bell AS; Swieboda DP; Morales-Sanfrutos J; Pérez-Dorado I; Brannigan JA; Newman J; et al. "Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus.". Nature chemistry (2018): http://europepmc.org/abstract/med/29760414.
    10.1038/s41557-018-0039-2
  63. Anja C. Schlott; Anthony A. Holder; Edward W. Tate. "N-Myristoylation as a Drug Target in Malaria: Exploring the Role of N-Myristoyltransferase Substrates in the Inhibitor Mode of Action". ACS Infectious Diseases (2018): https://doi.org/10.1021/acsinfecdis.7b00203.
    10.1021/acsinfecdis.7b00203
  64. Alexandra S. Lubin; Ainoa Rueda-Zubiaurre; Holly Matthews; Hella Baumann; Fabio R. Fisher; Julia Morales-Sanfrutos; Kate S. Hadavizadeh; et al. "Development of a Photo-Cross-Linkable Diaminoquinazoline Inhibitor for Target Identification in Plasmodium falciparum". ACS Infectious Diseases (2018): https://doi.org/10.1021/acsinfecdis.7b00228.
    10.1021/acsinfecdis.7b00228
  65. Pollard DJ; Berger CN; So EC; Yu L; Hadavizadeh K; Jennings P; Tate EW; Choudhary JS; Frankel G. "Broad-Spectrum Regulation of Nonreceptor Tyrosine Kinases by the Bacterial ADP-Ribosyltransferase EspJ.". mBio (2018): http://europepmc.org/abstract/med/29636436.
    10.1128/mBio.00170-18
  66. Beard R; Stucki A; Schmitt M; Py G; Grundschober C; Gee AD; Tate EW. "Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs.". Bioorganic & medicinal chemistry (2018): http://europepmc.org/abstract/med/29602673.
    10.1016/j.bmc.2018.03.019
  67. Rhiannon Beard; Nisha Singh; Christophe Grundschober; Antony D. Gee; Edward W. Tate. "High-yielding 18F radiosynthesis of a novel oxytocin receptor tracer, a probe for nose-to-brain oxytocin uptake in vivo". Chemical Communications (2018): https://doi.org/10.1039/C8CC01400K.
    10.1039/C8CC01400K
  68. Ritzefeld, M.; Wright, M.H.; Tate, E.W.; Ritzefeld M; Wright MH; Tate EW. "New developments in probing and targeting protein acylation in malaria, leishmaniasis and African sleeping sickness". Parasitology 145 2 (2018): 157-174. http://www.scopus.com/inward/record.url?eid=2-s2.0-85014635940&partnerID=MN8TOARS.
    10.1017/S0031182017000282
  69. Beard, R.; Singh, N.; Grundschober, C.; Gee, A.D.; Tate, E.W.. "High-yielding 18F radiosynthesis of a novel oxytocin receptor tracer, a probe for nose-to-brain oxytocin uptake in vivo". Chemical Communications 54 58 (2018): 8120-8123. http://www.scopus.com/inward/record.url?eid=2-s2.0-85050193713&partnerID=MN8TOARS.
    10.1039/c8cc01400k
  70. Pranzatelli MR; Tate ED; McGee NR. "Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study.". Frontiers in neurology (2017): http://europepmc.org/abstract/med/28959231.
    10.3389/fneur.2017.00468
  71. Lanyon-Hogg T; Faronato M; Serwa RA; Tate EW. "Dynamic Protein Acylation: New Substrates, Mechanisms, and Drug Targets.". Trends in biochemical sciences (2017): http://europepmc.org/abstract/med/28602500.
    10.1016/j.tibs.2017.04.004
  72. Clulow JA; Storck EM; Lanyon-Hogg T; Kalesh KA; Jones LH; Tate EW. "Competition-based, quantitative chemical proteomics in breast cancer cells identifies new target profiles for sulforaphane.". Chemical communications (Cambridge, England) (2017): http://europepmc.org/abstract/med/28439590.
    10.1039/c6cc08797c
  73. Duluc L; Ahmetaj-Shala B; Mitchell J; Abdul-Salam VB; Mahomed AS; Aldabbous L; Oliver E; et al. "Tipifarnib prevents development of hypoxia-induced pulmonary hypertension.". Cardiovascular research (2017): http://europepmc.org/abstract/med/28395021.
    10.1093/cvr/cvw258
  74. Zhao W; Jamshidiha M; Lanyon-Hogg T; Recchi C; Cota E; Tate EW. "Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design.". Current topics in medicinal chemistry (2017): http://europepmc.org/abstract/med/27530972.
    10.2174/1568026616666160719165633
  75. Perdios L; Lowe AR; Saladino G; Bunney TD; Thiyagarajan N; Alexandrov Y; Dunsby C; et al. "Conformational transition of FGFR kinase activation revealed by site-specific unnatural amino acid reporter and single molecule FRET.". Scientific reports (2017): http://europepmc.org/abstract/med/28045057.
    10.1038/srep39841
  76. Görlitz F; Kelly DJ; Warren SC; Alibhai D; West L; Kumar S; Alexandrov Y; et al. "Open Source High Content Analysis Utilizing Automated Fluorescence Lifetime Imaging Microscopy.". Journal of visualized experiments : JoVE (2017): http://europepmc.org/abstract/med/28190060.
    10.3791/55119
  77. Demetriadou A; Morales-Sanfrutos J; Nearchou M; Baba O; Kyriacou K; Tate EW; Drousiotou A; Petrou PP. "Mouse Stbd1 is N-myristoylated and affects ER-mitochondria association and mitochondrial morphology.". Journal of cell science (2017): http://europepmc.org/abstract/med/28137759.
    10.1242/jcs.195263
  78. Lanyon-Hogg T; Patel NV; Ritzefeld M; Boxall KJ; Burke R; Blagg J; Magee AI; Tate EW. "Microfluidic Mobility Shift Assay for Real-Time Analysis of Peptide N-Palmitoylation.". SLAS discovery : advancing life sciences R & D (2017): http://europepmc.org/abstract/med/28296537.
    10.1177/2472555216689529
  79. Goncalves V; Brannigan JA; Laporte A; Bell AS; Roberts SM; Wilkinson AJ; Leatherbarrow RJ; Tate EW. "Structure-guided optimization of quinoline inhibitors of Plasmodium N-myristoyltransferase.". MedChemComm (2016): http://europepmc.org/abstract/med/28626547.
    10.1039/c6md00531d
  80. Rodgers UR; Lanyon-Hogg T; Masumoto N; Ritzefeld M; Burke R; Blagg J; Magee AI; Tate EW. "Characterization of Hedgehog Acyltransferase Inhibitors Identifies a Small Molecule Probe for Hedgehog Signaling by Cancer Cells.". ACS chemical biology (2016): http://europepmc.org/abstract/med/27779865.
    10.1021/acschembio.6b00896
  81. Ward JA; McLellan L; Stockley M; Gibson KR; Whitlock GA; Knights C; Harrigan JA; Jacq X; Tate EW. "Quantitative Chemical Proteomic Profiling of Ubiquitin Specific Proteases in Intact Cancer Cells.". ACS chemical biology (2016): http://europepmc.org/abstract/med/27779380.
    10.1021/acschembio.6b00766
  82. Thinon E; Morales-Sanfrutos J; Mann DJ; Tate EW. "N-Myristoyltransferase Inhibition Induces ER-Stress, Cell Cycle Arrest, and Apoptosis in Cancer Cells.". ACS chemical biology (2016): http://europepmc.org/abstract/med/27267252.
    10.1021/acschembio.6b00371
  83. Albrow VE; Grimley RL; Clulow J; Rose CR; Sun J; Warmus JS; Tate EW; Jones LH; Storer RI. "Design and development of histone deacetylase (HDAC) chemical probes for cell-based profiling.". Molecular bioSystems (2016): http://europepmc.org/abstract/med/27021930.
    10.1039/c6mb00109b
  84. Wright MH; Paape D; Price HP; Smith DF; Tate EW. "Global Profiling and Inhibition of Protein Lipidation in Vector and Host Stages of the Sleeping Sickness Parasite Trypanosoma brucei.". ACS infectious diseases (2016): http://europepmc.org/abstract/med/27331140.
    10.1021/acsinfecdis.6b00034
  85. Lanyon-Hogg T; Masumoto N; Bodakh G; Konitsiotis AD; Thinon E; Rodgers UR; Owens RJ; Magee AI; Tate EW. "Synthesis and characterisation of 5-acyl-6,7-dihydrothieno[3,2-c]pyridine inhibitors of Hedgehog acyltransferase.". Data in Brief (2016): http://europepmc.org/abstract/med/27077078.
    10.1016/j.dib.2016.02.012
  86. Broncel, M.; Serwa, R.A.; Bunney, T.D.; Katan, M.; Tate, E.W.. "Global profiling of huntingtin-Associated protein e (HYPE)-mediated Ampylation through a chemical proteomic approach". Molecular and Cellular Proteomics 15 2 (2016): 715-725. http://www.scopus.com/inward/record.url?eid=2-s2.0-84957900425&partnerID=MN8TOARS.
    10.1074/mcp.O115.054429
  87. So, E.C.; Schroeder, G.N.; Carson, D.; Mattheis, C.; Mousnier, A.; Broncel, M.; Tate, E.W.; et al. "The Rab-binding profiles of bacterial virulence factors during infection". Journal of Biological Chemistry 291 11 (2016): 5832-5843. http://www.scopus.com/inward/record.url?eid=2-s2.0-84973375954&partnerID=MN8TOARS.
    10.1074/jbc.M115.700930
  88. Charlton TM; Kovacs-Simon A; Michell SL; Fairweather NF; Tate EW. "Quantitative Lipoproteomics in Clostridium difficile Reveals a Role for Lipoproteins in Sporulation.". Chemistry & biology (2015): http://europepmc.org/abstract/med/26584780.
    10.1016/j.chembiol.2015.10.006
  89. Broncel M; Serwa RA; Bunney TD; Katan M; Tate EW. "Global Profiling of Huntingtin-associated protein E (HYPE)-Mediated AMPylation through a Chemical Proteomic Approach.". Molecular & cellular proteomics : MCP (2015): http://europepmc.org/abstract/med/26604261.
    10.1074/mcp.o115.054429
  90. Lanyon-Hogg T; Masumoto N; Bodakh G; Konitsiotis AD; Thinon E; Rodgers UR; Owens RJ; Magee AI; Tate EW. "Click chemistry armed enzyme-linked immunosorbent assay to measure palmitoylation by hedgehog acyltransferase.". Analytical biochemistry (2015): http://europepmc.org/abstract/med/26334609.
    10.1016/j.ab.2015.08.025
  91. Perdios L; Bunney TD; Warren SC; Dunsby C; French PMW; Tate EW; Katan M. "Time-resolved FRET reports FGFR1 dimerization and formation of a complex with its effector PLC¿1.". Advances in biological regulation (2015): http://europepmc.org/abstract/med/26482290.
    10.1016/j.jbior.2015.09.002
  92. Serwa RA; Abaitua F; Krause E; Tate EW; O'Hare P. "Systems Analysis of Protein Fatty Acylation in Herpes Simplex Virus-Infected Cells Using Chemical Proteomics.". Chemistry & biology (2015): http://europepmc.org/abstract/med/26256475.
    10.1016/j.chembiol.2015.06.024
  93. Rackham MD; Yu Z; Brannigan JA; Heal WP; Paape D; Barker KV; Wilkinson AJ; et al. "Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase.". MedChemComm (2015): http://europepmc.org/abstract/med/26962429.
    10.1039/c5md00241a
  94. Yu Z; Brannigan JA; Rangachari K; Heal WP; Wilkinson AJ; Holder AA; Leatherbarrow RJ; Tate EW. "Discovery of pyridyl-based inhibitors of Plasmodium falciparum N-myristoyltransferase.". MedChemComm (2015): http://europepmc.org/abstract/med/26962430.
    10.1039/c5md00242g
  95. Broncel M; Serwa RA; Ciepla P; Krause E; Dallman MJ; Magee AI; Tate EW. "Myristoylation profiling in human cells and zebrafish.". Data in brief (2015): http://europepmc.org/abstract/med/26217820.
    10.1016/j.dib.2015.06.010
  96. Nickel S; Serwa RA; Kaschani F; Ninck S; Zweerink S; Tate EW; Kaiser M. "Chemoproteomic Evaluation of the Polyacetylene Callyspongynic Acid.". Chemistry (Weinheim an der Bergstrasse, Germany) (2015): http://europepmc.org/abstract/med/26079733.
    10.1002/chem.201500934
  97. So EC; Mattheis C; Tate EW; Frankel G; Schroeder GN. "Creating a customized intracellular niche: subversion of host cell signaling by Legionella type IV secretion system effectors.". Canadian journal of microbiology (2015): http://europepmc.org/abstract/med/26059316.
    10.1139/cjm-2015-0166
  98. Lanyon-Hogg T; Ritzefeld M; Masumoto N; Magee AI; Rzepa HS; Tate EW. "Modulation of Amide Bond Rotamers in 5-Acyl-6,7-dihydrothieno[3,2-c]pyridines.". The Journal of organic chemistry (2015): http://europepmc.org/abstract/med/25713927.
    10.1021/acs.joc.5b00205
  99. Kalesh KA; Clulow JA; Tate EW. "Target profiling of zerumbone using a novel cell-permeable clickable probe and quantitative chemical proteomics.". Chemical communications (Cambridge, England) (2015): http://europepmc.org/abstract/med/25598414.
    10.1039/c4cc09527h
  100. Yusuf NA; Green JL; Wall RJ; Knuepfer E; Moon RW; Schulte-Huxel C; Stanway RR; et al. "The Plasmodium Class XIV Myosin, MyoB, Has a Distinct Subcellular Location in Invasive and Motile Stages of the Malaria Parasite and an Unusual Light Chain.". The Journal of biological chemistry (2015): http://europepmc.org/abstract/med/25802338.
    10.1074/jbc.m115.637694
  101. Broncel M; Serwa RA; Ciepla P; Krause E; Dallman MJ; Magee AI; Tate EW. "Multifunctional reagents for quantitative proteome-wide analysis of protein modification in human cells and dynamic profiling of protein lipidation during vertebrate development.". Angewandte Chemie (International ed. in English) (2015): http://europepmc.org/abstract/med/25807930.
    10.1002/anie.201500342
  102. Wright MH; Paape D; Storck EM; Serwa RA; Smith DF; Tate EW. "Global analysis of protein N-myristoylation and exploration of N-myristoyltransferase as a drug target in the neglected human pathogen Leishmania donovani.". Chemistry & biology (2015): http://europepmc.org/abstract/med/25728269.
    10.1016/j.chembiol.2015.01.003
  103. Furse S; Mak L; Tate EW; Templer RH; Ces O; Woscholski R; Gaffney PR. "Synthesis of unsaturated phosphatidylinositol 4-phosphates and the effects of substrate unsaturation on SopB phosphatase activity.". Organic & biomolecular chemistry (2015): http://europepmc.org/abstract/med/25515724.
    10.1039/c4ob02258k
  104. Masumoto, N.; Lanyon-Hogg, T.; Rodgers, U.R.; Konitsiotis, A.D.; Magee, A.I.; Tate, E.W.; Masumoto N; et al. "Membrane bound O-acyltransferases and their inhibitors". Biochemical Society Transactions 43 (2015): 246-252. http://www.scopus.com/inward/record.url?eid=2-s2.0-84935020895&partnerID=MN8TOARS.
    10.1042/BST20150018
  105. Schroeder, G.N.; Aurass, P.; Oates, C.V.; Tate, E.W.; Hartland, E.L.; Flieger, A.; Frankel, G.; et al. "Legionella pneumophila effector LpdA Is a palmitoylated phospholipase D virulence factor". Infection and Immunity 83 10 (2015): 3989-4002. http://www.scopus.com/inward/record.url?eid=2-s2.0-84944446943&partnerID=MN8TOARS.
    10.1128/IAI.00785-15
  106. Yusuf, N.A.; Green, J.L.; Wall, R.J.; Knuepfer, E.; Moon, R.W.; Schulte-Huxel, C.; Stanway, R.R.; et al. "The Plasmodium class XIV Myosin, MyoB, has a distinct subcellular location in invasive and motile stages of the malaria parasite and an unusual light chain". Journal of Biological Chemistry 290 19 (2015): 12147-12164. http://www.scopus.com/inward/record.url?eid=2-s2.0-84929095673&partnerID=MN8TOARS.
    10.1074/jbc.M115.637694
  107. Kelly, D.J.; Warren, S.C.; Alibhai, D.; Kumar, S.; Alexandrov, Y.; Munro, I.; Margineanu, A.; et al. "Automated multiwell fluorescence lifetime imaging for Förster resonance energy transfer assays and high content analysis". Analytical Methods 7 10 (2015): 4071-4089. http://www.scopus.com/inward/record.url?eid=2-s2.0-84929378119&partnerID=MN8TOARS.
    10.1039/c5ay00244c
  108. Ciepla, P.; Magee, A.I.; Tate, E.W.; Ciepla P; Magee AI; Tate EW. "Cholesterylation: A tail of hedgehog". Biochemical Society Transactions 43 (2015): 262-267. http://www.scopus.com/inward/record.url?eid=2-s2.0-84934935737&partnerID=MN8TOARS.
    10.1042/BST20150032
  109. Bunney TD; Cole AR; Broncel M; Esposito D; Tate EW; Katan M. "Crystal structure of the human, FIC-domain containing protein HYPE and implications for its functions.". Structure (London, England : 1993) (2014): http://europepmc.org/abstract/med/25435325.
    10.1016/j.str.2014.10.007
  110. Konitsiotis AD; Jovanovic B; Ciepla P; Spitaler M; Lanyon-Hogg T; Tate EW; Magee AI; et al. "Topological analysis of Hedgehog acyltransferase, a multipalmitoylated transmembrane protein.". The Journal of biological chemistry 290 6 (2014): 3293-3307. http://europepmc.org/abstract/med/25505265.
    10.1074/jbc.m114.614578
  111. Paape D; Bell AS; Heal WP; Hutton JA; Leatherbarrow RJ; Tate EW; Smith DF. "Using a non-image-based medium-throughput assay for screening compounds targeting N-myristoylation in intracellular Leishmania amastigotes.". PLoS neglected tropical diseases (2014): http://europepmc.org/abstract/med/25522361.
    10.1371/journal.pntd.0003363
  112. Douse CH; Vrielink N; Wenlin Z; Cota E; Tate EW. "Targeting a dynamic protein-protein interaction: fragment screening against the malaria myosin A motor complex.". ChemMedChem (2014): http://europepmc.org/abstract/med/25367834.
    10.1002/cmdc.201402357
  113. Tate EW; Kalesh KA; Lanyon-Hogg T; Storck EM; Thinon E. "Global profiling of protein lipidation using chemical proteomic technologies.". Current opinion in chemical biology (2014): http://europepmc.org/abstract/med/25461723.
    10.1016/j.cbpa.2014.10.016
  114. Hutton JA; Goncalves V; Brannigan JA; Paape D; Wright MH; Waugh TM; Roberts SM; et al. "Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors.". Journal of medicinal chemistry (2014): http://europepmc.org/abstract/med/25238611.
    10.1021/jm5011397
  115. Thinon E; Serwa RA; Broncel M; Brannigan JA; Brassat U; Wright MH; Heal WP; et al. "Global profiling of co- and post-translationally N-myristoylated proteomes in human cells.". Nature communications (2014): http://europepmc.org/abstract/med/25255805.
    10.1038/ncomms5919
  116. Olaleye TO; Brannigan JA; Roberts SM; Leatherbarrow RJ; Wilkinson AJ; Tate EW. "Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites.". Organic & biomolecular chemistry (2014): http://europepmc.org/abstract/med/25230674.
    10.1039/c4ob01669f
  117. Douse CH; Maas SJ; Thomas JC; Garnett JA; Sun Y; Cota E; Tate EW. "Crystal structures of stapled and hydrogen bond surrogate peptides targeting a fully buried protein-helix interaction.". ACS chemical biology (2014): http://europepmc.org/abstract/med/25084543.
    10.1021/cb500271c
  118. Kalesh KA; Tate EW. "A succinyl lysine-based photo-cross-linking peptide probe for Sirtuin 5.". Organic & biomolecular chemistry (2014): http://europepmc.org/abstract/med/24848608.
    10.1039/c4ob00773e
  119. Guttery DS; Poulin B; Ramaprasad A; Wall RJ; Ferguson DJ; Brady D; Patzewitz EM; et al. "Genome-wide functional analysis of Plasmodium protein phosphatases reveals key regulators of parasite development and differentiation.". Cell host & microbe (2014): http://europepmc.org/abstract/med/25011111.
    10.1016/j.chom.2014.05.020
  120. Ciepla P; Konitsiotis AD; Serwa RA; Masumoto N; Leong WP; Dallman MJ; Magee AI; Tate EW. "New chemical probes targeting cholesterylation of Sonic Hedgehog in human cells and zebrafish.". Chemical science (2014): http://europepmc.org/abstract/med/25574372.
    10.1039/c4sc01600a
  121. Gray K; Elghadban S; Thongyoo P; Owen KA; Szabo R; Bugge TH; Tate EW; et al. "Potent and specific inhibition of the biological activity of the type-II transmembrane serine protease matriptase by the cyclic microprotein MCoTI-II.". Thrombosis and haemostasis 112 2 (2014): 402-411. http://europepmc.org/abstract/med/24696092.
    10.1160/th13-11-0895
  122. Rackham MD; Brannigan JA; Rangachari K; Meister S; Wilkinson AJ; Holder AA; Leatherbarrow RJ; Tate EW. "Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP).". Journal of medicinal chemistry (2014): http://europepmc.org/abstract/med/24641010.
    10.1021/jm500066b
  123. Konitsiotis AD; Chang SC; Jovanovic B; Ciepla P; Masumoto N; Palmer CP; Tate EW; Couchman JR; Magee AI. "Attenuation of hedgehog acyltransferase-catalyzed sonic Hedgehog palmitoylation causes reduced signaling, proliferation and invasiveness of human carcinoma cells.". PloS one (2014): http://europepmc.org/abstract/med/24608521.
    10.1371/journal.pone.0089899
  124. Brannigan, J.A.; Roberts, S.M.; Bell, A.S.; Hutton, J.A.; Hodgkinson, M.R.; Tate, E.W.; Leatherbarrow, R.J.; et al. "Diverse modes of binding in structures of Leishmania major N-myristoyltransferase with selective inhibitors". IUCrJ 1 (2014): 250-260. http://www.scopus.com/inward/record.url?eid=2-s2.0-84908364091&partnerID=MN8TOARS.
    10.1107/S2052252514013001
  125. Wright MH; Clough B; Rackham MD; Rangachari K; Brannigan JA; Grainger M; Moss DK; et al. "Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach.". Nature chemistry (2013): http://europepmc.org/abstract/med/24451586.
    10.1038/nchem.1830
  126. Poulin B; Patzewitz EM; Brady D; Silvie O; Wright MH; Ferguson DJ; Wall RJ; et al. "Unique apicomplexan IMC sub-compartment proteins are early markers for apical polarity in the malaria parasite.". Biology open (2013): http://europepmc.org/abstract/med/24244852.
    10.1242/bio.20136163
  127. Tate EW; Bell AS; Rackham MD; Wright MH; Tate, E.W.; Bell, A.S.; Rackham, M.D.; Wright, M.H.. "N-Myristoyltransferase as a potential drug target in malaria and leishmaniasis.". Parasitology 141 1 (2013): 37-49. http://europepmc.org/abstract/med/23611109.
    10.1017/s0031182013000450
  128. Storck, E.M.; Serwa, R.A.; Tate, E.W.; Storck EM; Serwa RA; Tate EW. "Chemical proteomics: A powerful tool for exploring protein lipidation". Biochemical Society Transactions 41 1 (2013): 56-61. http://www.scopus.com/inward/record.url?eid=2-s2.0-84873127663&partnerID=MN8TOARS.
    10.1042/BST20120283
  129. Rackham MD; Brannigan JA; Moss DK; Yu Z; Wilkinson AJ; Holder AA; Tate EW; Leatherbarrow RJ. "Discovery of novel and ligand-efficient inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferase.". Journal of medicinal chemistry (2012): http://europepmc.org/abstract/med/23170970.
    10.1021/jm301474t
  130. Alibhai D; Kelly DJ; Warren S; Kumar S; Margineau A; Serwa RA; Thinon E; et al. "Automated fluorescence lifetime imaging plate reader and its application to Förster resonant energy transfer readout of Gag protein aggregation.". Journal of biophotonics (2012): http://europepmc.org/abstract/med/23184449.
    10.1002/jbio.201200185
  131. Yu Z; Brannigan JA; Moss DK; Brzozowski AM; Wilkinson AJ; Holder AA; Tate EW; Leatherbarrow RJ. "Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.". Journal of medicinal chemistry (2012): http://europepmc.org/abstract/med/23035716.
    10.1021/jm301160h
  132. Price HP; Hodgkinson MR; Wright MH; Tate EW; Smith BA; Carrington M; Stark M; Smith DF. "A role for the vesicle-associated tubulin binding protein ARL6 (BBS3) in flagellum extension in Trypanosoma brucei.". Biochimica et biophysica acta (2012): http://europepmc.org/abstract/med/22609302.
    10.1016/j.bbamcr.2012.05.007
  133. Goncalves V; Brannigan JA; Whalley D; Ansell KH; Saxty B; Holder AA; Wilkinson AJ; Tate EW; Leatherbarrow RJ. "Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode.". Journal of medicinal chemistry (2012): http://europepmc.org/abstract/med/22439843.
    10.1021/jm300040p
  134. Bell AS; Mills JE; Williams GP; Brannigan JA; Wilkinson AJ; Parkinson T; Leatherbarrow RJ; et al. "Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs.". PLoS neglected tropical diseases (2012): http://europepmc.org/abstract/med/22545171.
    10.1371/journal.pntd.0001625
  135. Heal WP; Tate EW. "Application of activity-based protein profiling to the study of microbial pathogenesis.". Topics in current chemistry (2012): http://europepmc.org/abstract/med/22102218.
    10.1007/128_2011_299
  136. Broncel M; Serwa RA; Tate EW. "A new chemical handle for protein AMPylation at the host-pathogen interface.". Chembiochem : a European journal of chemical biology (2012): http://europepmc.org/abstract/med/22213418.
    10.1002/cbic.201100743
  137. Furse, S.; Brooks, N.J.; Seddon, A.M.; Woscholski, R.; Templer, R.H.; Tate, E.W.; Gaffney, P.R.J.; Ces, O.. "Lipid membrane curvature induced by distearoyl phosphatidylinositol 4-phosphate". Soft Matter 8 11 (2012): 3090-3093. http://www.scopus.com/inward/record.url?eid=2-s2.0-84857713751&partnerID=MN8TOARS.
    10.1039/c2sm07358g
  138. Douse, C.H.; Green, J.L.; Salgado, P.S.; Simpson, P.J.; Thomas, J.C.; Langsley, G.; Holder, A.A.; et al. "Regulation of the plasmodium motor complex: Phosphorylation of myosin a tail-interacting protein (MTIP) loosens its grip on MyoA". Journal of Biological Chemistry 287 44 (2012): 36968-36977. http://www.scopus.com/inward/record.url?eid=2-s2.0-84868223075&partnerID=MN8TOARS.
    10.1074/jbc.M112.379842
  139. Bradshaw, R.T.; Aronica, P.G.A.; Tate, E.W.; Leatherbarrow, R.J.; Gould, I.R.. "Mutational Locally Enhanced Sampling (MULES) for quantitative prediction of the effects of mutations at protein-protein interfaces". Chemical Science 3 5 (2012): 1503-1511. http://www.scopus.com/inward/record.url?eid=2-s2.0-84859327089&partnerID=MN8TOARS.
    10.1039/c2sc00895e
  140. Heal WP; Wright MH; Thinon E; Tate EW. "Multifunctional protein labeling via enzymatic N-terminal tagging and elaboration by click chemistry.". Nature protocols (2011): http://europepmc.org/abstract/med/22193303.
    10.1038/nprot.2011.425
  141. Goncalves V; Brannigan JA; Thinon E; Olaleye TO; Serwa R; Lanzarone S; Wilkinson AJ; Tate EW; Leatherbarrow RJ. "A fluorescence-based assay for N-myristoyltransferase activity.". Analytical biochemistry (2011): http://europepmc.org/abstract/med/22051857.
    10.1016/j.ab.2011.10.013
  142. Delmotte A; Tate EW; Yaliraki SN; Barahona M. "Protein multi-scale organization through graph partitioning and robustness analysis: application to the myosin-myosin light chain interaction.". Physical biology (2011): http://europepmc.org/abstract/med/21832797.
    10.1088/1478-3975/8/5/055010
  143. Tate EW; Goss RJ. "Highlights from the 46th EUCHEM Conference on stereochemistry, Bürgenstock, Switzerland, May 2011.". Chemical communications (Cambridge, England) (2011): http://europepmc.org/abstract/med/21874182.
    10.1039/c1cc90123k
  144. Tam Dang TH; Fagan RP; Fairweather NF; Tate EW. "Novel inhibitors of surface layer processing in Clostridium difficile.". Bioorganic & medicinal chemistry (2011): http://europepmc.org/abstract/med/21752656.
    10.1016/j.bmc.2011.06.042
  145. Serwa R; Tate EW. "Activity-based profiling for drug discovery.". Chemistry & biology (2011): http://europepmc.org/abstract/med/21513874.
    10.1016/j.chembiol.2011.04.002
  146. de la Riva L; Willing SE; Tate EW; Fairweather NF; de la Riva, L.; Willing, S.E.; Tate, E.W.; Fairweather, N.F.. "Roles of cysteine proteases Cwp84 and Cwp13 in biogenesis of the cell wall of Clostridium difficile.". Journal of bacteriology 193 13 (2011): 3276-3285. http://europepmc.org/abstract/med/21531808.
    10.1128/jb.00248-11
  147. Heal WP; Jovanovic B; Bessin S; Wright MH; Magee AI; Tate EW. "Bioorthogonal chemical tagging of protein cholesterylation in living cells.". Chemical communications (Cambridge, England) (2011): http://europepmc.org/abstract/med/21221452.
    10.1039/c0cc04710d
  148. Heal WP; Dang TH; Tate EW. "Activity-based probes: discovering new biology and new drug targets.". Chemical Society reviews (2010): http://europepmc.org/abstract/med/20886146.
    10.1039/c0cs00004c
  149. Bradshaw RT; Patel BH; Tate EW; Leatherbarrow RJ; Gould IR. "Comparing experimental and computational alanine scanning techniques for probing a prototypical protein-protein interaction.". Protein engineering, design & selection : PEDS (2010): http://europepmc.org/abstract/med/20656696.
    10.1093/protein/gzq047
  150. Berry AF; Heal WP; Tarafder AK; Tolmachova T; Baron RA; Seabra MC; Tate EW. "Rapid multilabel detection of geranylgeranylated proteins by using bioorthogonal ligation chemistry.". Chembiochem : a European journal of chemical biology (2010): http://europepmc.org/abstract/med/20209562.
    10.1002/cbic.201000087
  151. Dang TH; de la Riva L; Fagan RP; Storck EM; Heal WP; Janoir C; Fairweather NF; Tate EW. "Chemical probes of surface layer biogenesis in Clostridium difficile.". ACS chemical biology (2010): http://europepmc.org/abstract/med/20067320.
    10.1021/cb9002859
  152. So S; Peeva LG; Tate EW; Leatherbarrow RJ; Livingston AG. "Membrane enhanced peptide synthesis.". Chemical communications (Cambridge, England) (2010): http://europepmc.org/abstract/med/20369190.
    10.1039/b926747f
  153. Thomas JC; Green JL; Howson RI; Simpson P; Moss DK; Martin SR; Holder AA; Cota E; Tate EW. "Interaction and dynamics of the Plasmodium falciparum MTIP-MyoA complex, a key component of the invasion motor in the malaria parasite.". Molecular bioSystems (2010): http://europepmc.org/abstract/med/20174678.
    10.1039/b922093c
  154. So, S.; Peeva, L.G.; Tate, E.W.; Leatherbarrow, R.J.; Livingston, A.G.. "Organic solvent nanofiltration: A new paradigm in peptide synthesis". Organic Process Research and Development 14 6 (2010): 1313-1325. http://www.scopus.com/inward/record.url?eid=2-s2.0-78649643372&partnerID=MN8TOARS.
    10.1021/op1001403
  155. Heal WP; Tate EW. "Getting a chemical handle on protein post-translational modification.". Organic & biomolecular chemistry (2009): http://europepmc.org/abstract/med/20135026.
    10.1039/b917894e
  156. Brannigan JA; Smith BA; Yu Z; Brzozowski AM; Hodgkinson MR; Maroof A; Price HP; et al. "N-myristoyltransferase from Leishmania donovani: structural and functional characterisation of a potential drug target for visceral leishmaniasis.". Journal of molecular biology (2009): http://europepmc.org/abstract/med/20036251.
    10.1016/j.jmb.2009.12.032
  157. Wright MH; Heal WP; Mann DJ; Tate EW. "Protein myristoylation in health and disease.". Journal of chemical biology (2009): http://europepmc.org/abstract/med/19898886.
    10.1007/s12154-009-0032-8
  158. Thongyoo P; Bonomelli C; Leatherbarrow RJ; Tate EW. "Potent inhibitors of beta-tryptase and human leukocyte elastase based on the MCoTI-II scaffold.". Journal of medicinal chemistry (2009): http://europepmc.org/abstract/med/19772295.
    10.1021/jm901233u
  159. Heal WP; Wickramasinghe SR; Tate EW. "Activity based chemical proteomics: profiling proteases as drug targets.". Current drug discovery technologies (2008): http://europepmc.org/abstract/med/18690889.
    10.2174/157016308785739866
  160. Busch GK; Tate EW; Gaffney PR; Rosivatz E; Woscholski R; Leatherbarrow RJ. "Specific N-terminal protein labelling: use of FMDV 3C pro protease and native chemical ligation.". Chemical communications (Cambridge, England) (2008): http://europepmc.org/abstract/med/18633492.
    10.1039/b806727a
  161. Tate EW. "Recent advances in chemical proteomics: exploring the post-translational proteome.". Journal of chemical biology (2008): http://europepmc.org/abstract/med/19568795.
    10.1007/s12154-008-0002-6
  162. Heal WP; Wickramasinghe SR; Leatherbarrow RJ; Tate EW. "N-Myristoyl transferase-mediated protein labelling in vivo.". Organic & biomolecular chemistry (2008): http://europepmc.org/abstract/med/18563263.
    10.1039/b803258k
  163. Bowyer PW; Tate EW; Leatherbarrow RJ; Holder AA; Smith DF; Brown KA. "N-myristoyltransferase: a prospective drug target for protozoan parasites.". ChemMedChem (2008): http://europepmc.org/abstract/med/18324715.
    10.1002/cmdc.200700301
  164. Thongyoo P; Roqué-Rosell N; Leatherbarrow RJ; Tate EW. "Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides.". Organic & biomolecular chemistry (2008): http://europepmc.org/abstract/med/18385853.
    10.1039/b801667d
  165. Bowyer PW; Gunaratne RS; Grainger M; Withers-Martinez C; Wickramsinghe SR; Tate EW; Leatherbarrow RJ; et al. "Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of Plasmodium falciparum.". The Biochemical journal 408 2 (2007): 173-180. http://europepmc.org/abstract/med/17714074.
    10.1042/bj20070692
  166. Heal WP; Wickramasinghe SR; Bowyer PW; Holder AA; Smith DF; Leatherbarrow RJ; Tate EW. "Site-specific N-terminal labelling of proteins in vitro and in vivo using N-myristoyl transferase and bioorthogonal ligation chemistry.". Chemical communications (Cambridge, England) (2007): http://europepmc.org/abstract/med/18188474.
    10.1039/b716115h
  167. Thongyoo P; Jaulent AM; Tate EW; Leatherbarrow RJ. "Immobilized protease-assisted synthesis of engineered cysteine-knot microproteins.". Chembiochem : a European journal of chemical biology (2007): http://europepmc.org/abstract/med/17526063.
    10.1002/cbic.200700187
  168. Thongyoo P; Tate EW; Leatherbarrow RJ. "Total synthesis of the macrocyclic cysteine knot microprotein MCoTI-II.". Chemical communications (Cambridge, England) (2006): http://europepmc.org/abstract/med/17007393.
    10.1039/b607324g
  169. Tate EW; Dixon DJ; Ley SV. "A highly enantioselective total synthesis of (+)-goniodiol.". Organic & biomolecular chemistry (2006): http://europepmc.org/abstract/med/16633562.
    10.1039/b602805e
  170. Tate, E.W.. "Chemical intervention in signalling networks: Recent advances and applications". Signal Transduction 6 2 (2006): 144-159. http://www.scopus.com/inward/record.url?eid=2-s2.0-33646372429&partnerID=MN8TOARS.
    10.1002/sita.200500075
  171. Tate, E.W.; Bowyer, P.W.; Brown, K.A.; Smith, D.F.; Holder, A.A.; Leatherbarrow, R.J.. "Peptide-based inhibitors of N-myristoyl transferase generated from a lipid/combinatorial peptide chimera library". Signal Transduction 6 2 (2006): 160-166. http://www.scopus.com/inward/record.url?eid=2-s2.0-33646359916&partnerID=MN8TOARS.
    10.1002/sita.200500084
  172. Kalaï, C.; Tate, E.; Zard, S.Z.. "A short formal route to (±)-lepadin B using a xanthate-mediated free radical cyclisation/vinylation sequence". Chemical Communications 2 13 (2002): 1430-1431. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036080620&partnerID=MN8TOARS.
    10.1039/b203604e
  173. Tate, E.W.; Zard, S.Z.. "Efficient construction of polycyclic alkaloid synthetic precursors by a xanthate free radical addition and Mannich cyclisation cascade". Tetrahedron Letters 43 26 (2002): 4683-4686. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037189175&partnerID=MN8TOARS.
    10.1016/S0040-4039(02)00835-3
  174. Buffet, M.F.; Dixon, D.J.; Edwards, G.L.; Ley, S.V.; Tate, E.W.. "Oxygen to carbon rearrangements of anomerically linked alkenols from tetrahydropyran derivatives: An investigation of the reaction mechanism via a double isotopic labelling crossover study". Journal of the Chemical Society, Perkin Transactions 1 12 (2000): 1815-1827. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034697707&partnerID=MN8TOARS.
    10.1039/a909300a
  175. Dixon, D.J.; Ley, S.V.; Tate, E.W.. "The synthesis of mono- and bicyclic ethers via acid catalysed ring-opening cyclisation of tetrahyclropyranyl ether derivatives". Journal of the Chemical Society, Perkin Transactions 1 12 (2000): 1829-1836. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034697720&partnerID=MN8TOARS.
    10.1039/a909302h
  176. Dixon, D.J.; Ley, S.V.; Tate, E.W.. "Diastereoselective oxygen to carbon rearrangements of anomerically linked enol ethers and the total synthesis of (+)-(S,S)-cis-6-methyltetrahydropyran-2-ylacetic acid, a component of civet". Journal of the Chemical Society, Perkin Transactions 1 15 (2000): 2385-2394. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034618265&partnerID=MN8TOARS.
    10.1039/b001243m
  177. Dixon, D.J.; Ley, S.V.; Tate, E.W.. "Highly cis- or fraws-selective oxygen to carbon rearrangements of anomerically linked 6-substituted tetrahydropyranyl enol ethers". Journal of the Chemical Society - Perkin Transactions 1 19 (1999): 2665-2667. http://www.scopus.com/inward/record.url?eid=2-s2.0-0001322924&partnerID=MN8TOARS.
    10.1039/a904891j
  178. Dixon, D.J.; Ley, S.V.; Tate, E.W.. "A total synthesis of (+)-Goniodiol using an anomeric oxygen-to-carbon rearrangement". Journal of the Chemical Society - Perkin Transactions 1 19 (1998): 3125-3126. http://www.scopus.com/inward/record.url?eid=2-s2.0-33749115510&partnerID=MN8TOARS.
    10.1039/a806584e
  179. Buffet, M.F.; Dixon, D.J.; Ley, S.V.; Tate, E.W.. "Anomeric oxygen to carbon rearrangements of alkynyl tributylstannane derivatives of lactols". Synlett 10 (1998): 1091-1092. http://www.scopus.com/inward/record.url?eid=2-s2.0-0002282303&partnerID=MN8TOARS.
    10.1055/s-1998-1866
  180. Dixon, D.J.; Ley, S.V.; Tate, E.W.. "Diastereoselective anomeric oxygen to carbon rearrangements of silyl enol ether derivatives of lactols". Synlett 10 (1998): 1093-1095. http://www.scopus.com/inward/record.url?eid=2-s2.0-0002348183&partnerID=MN8TOARS.
    10.1055/s-1998-1867
  181. Buffet, M.F.; Dixon, D.J.; Edwards, G.L.; Ley, S.V.; Tate, E.. "A General C-Glycosidation Procedure via Anomeric Oxygen to Carbon Rearrangements of Tetrahydropyranyl Ether Derivatives". Synlett 1997 9 (1997): 1055-1056. http://www.scopus.com/inward/record.url?eid=2-s2.0-0001923328&partnerID=MN8TOARS.
    10.1055/s-1997-1531
Capítulo de livro
  1. Bickel, J.K.; Voisin, T.B.; Tate, E.W.; Bubeck, D.. "How Structures of Complement Complexes Guide Therapeutic Design". 273-295. 2021.
    10.1007/978-3-030-58971-4_7
Pré-impressão
  1. Rishi R. Shah; Elena De Vita; Daniel Conole; Preethi S. Sathyamurthi; Xinyue Zhang; Elliot Fellows; Carlos M. Fleites; et al. "Structure-guided design and optimization of covalent VHL-targeted sulfonyl fluoride PROTACs". 2023. https://doi.org/10.1101/2023.06.20.545773.
    10.1101/2023.06.20.545773
  2. Simeon D. Draganov; Michael J. Gruet; Daniel Conole; Cristina Balcells; Alexandros P. Siskos; Hector C. Keun; Dorian O. Haskard; Edward W. Tate. "Chemical Tools for Profiling the Intracellular ADP-ribosylated Proteome". 2023. https://doi.org/10.1101/2023.08.30.555609.
    10.1101/2023.08.30.555609
  3. Matthew E. H. White; Jesús Gil; Edward W. Tate. "Proteome-wide structure-based accessibility analysis of ligandable and detectable cysteines in chemoproteomic datasets". 2022. https://doi.org/10.1101/2022.12.12.518491.
    10.1101/2022.12.12.518491
  4. Lalita Priyamvada; Wouter W. Kallemeijn; Monica Faronato; Kimberly Wilkins; Cynthia S. Goldsmith; Catherine A. Cotter; Suany Ojeda; et al. "Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry". 2022. https://doi.org/10.1101/2022.06.13.495866.
    10.1101/2022.06.13.495866
  5. Emma C. Couves; Scott Gardner; Tomas B. Voisin; Jasmine K. Bickel; Phillip J. Stansfeld; Edward W. Tate; Doryen Bubeck. "Structural basis for membrane attack complex inhibition by CD59". 2022. https://doi.org/10.1101/2022.09.05.506672.
    10.1101/2022.09.05.506672
  6. Elizabeth V. K. Ledger; Katie Lau; Edward W. Tate; Andrew M. Edwards. "XerC is required for the repair of antibiotic- and immune-mediated DNA damage in Staphylococcus aureus". 2022. https://doi.org/10.1101/2022.09.04.506505.
    10.1101/2022.09.04.506505
  7. Roman O. Fedoryshchak; Andrii Gorelik; Mengjie Shen; Maria M. Shchepinova; Inmaculada Pérez-Dorado; Edward W. Tate. "Discovery of lipid-mediated protein-protein interactions in living cells using metabolic labeling with photoactivatable clickable probes". 2021. https://doi.org/10.1101/2021.12.15.472799.
    10.1101/2021.12.15.472799

Propriedade Intelectual

Patente
  1. Tate, Edward W.. 2017. "Compounds and their use as inhibitors of N-myristoyl transferase". Reino Unido.
  2. Tate, Edward W.. 2013. "Novel compounds and their use in therapy".

Outros

Outra produção
  1. Expression of mini-G proteins specifically halt cognate GPCR trafficking and intracellular signalling. 2021. Yusman Manchanda; Zenouska Ramchunder; Maria M Shchepinova; Guy A Rutter; Asuka Inoue; Edward W Tate; Ben Jones; Alejandra Tomas. https://doi.org/10.1101/2021.11.24.469908.
    10.1101/2021.11.24.469908
  2. Prioritization of antimicrobial targets by CRISPR-based oligo recombineering. 2021. HJ. Benns; M. Storch; J. Falco; FR. Fisher; E. Alves; CJ. Wincott; J. Baum; et al. https://doi.org/10.1101/2021.02.04.429737.
    10.1101/2021.02.04.429737
  3. Inhibition of protein N-myristoylation blocks Plasmodium falciparum intraerythrocytic development, egress, and invasion. 2020. Anja C. Schlott; Ellen Knuepfer; Judith L. Green; Philip Hobson; Aaron J. Borg; Julia Morales-Sanfrutos; Abigail J. Perrin; et al. https://doi.org/10.1101/2020.12.16.423054.
    10.1101/2020.12.16.423054
  4. Short chain fatty acids enhance expression and activity of the umami taste receptor in enteroendocrine cells via a Gai/o pathway. 2020. Matilda Shackley; Edward W. Tate; Alastair J.H. Brown; Gary Frost; Aylin C. Hanyaloglu. https://doi.org/10.1101/2020.06.01.127316.
    10.1101/2020.06.01.127316
  5. Endosomal free fatty acid receptor 2 signaling is essential for propionate-induced anorectic gut hormone release. 2020. Natarin Caengprasath; Noemi Gonzalez-Abuin; Maria Shchepinova; Yue Ma; Asuka Inoue; Edward W. Tate; Gary Frost; Aylin C. Hanyaloglu. https://doi.org/10.1101/2020.03.24.004762.
    10.1101/2020.03.24.004762
  6. CRISPR-TAPE: protein-centric CRISPR guide design for targeted proteome engineering. 2020. DP. Anderson; HJ. Benns; EW. Tate; MA Child. https://doi.org/10.1101/2020.02.26.965889.
    10.1101/2020.02.26.965889
  7. Wheat pathogen Zymoseptoria tritici N-myristoyltransferase inhibitors: on-target antifungal activity and an unusual metabolic defense mechanism. 2020. Roman O. Fedoryshchak; Cory A. Ocasio; Ben Strutton; Jo Mattocks; Andrew J. Corran; Edward W. Tate. https://doi.org/10.1101/2020.02.09.940536.
    10.1101/2020.02.09.940536
  8. A Caged E3 Ligase Ligand for PROTAC-Mediated Protein Degradation with Light. 2019. Cyrille Kounde; Maria M. Shchepinova; Edward Tate. https://doi.org/10.26434/chemrxiv.11350079.v2.
    10.26434/chemrxiv.11350079.v2
  9. A Caged E3 Ligase Ligand for PROTAC-Mediated Protein Degradation with Light. 2019. Cyrille Kounde; Maria M. Shchepinova; Edward Tate. https://doi.org/10.26434/chemrxiv.11350079.v1.
    10.26434/chemrxiv.11350079.v1
Atividades

Orientação

Título / Tema
Papel desempenhado
Curso (Tipo)
Instituição / Organização
2004 - Atual Supervisor, MRes Biomedical Physical Chemistry
Orientador
Imperial College London, Reino Unido
2004 - Atual Supervisor, 3rd year BSc and 4th year MSci projects
Orientador
Imperial College London, Reino Unido
2004 - Atual Supervisor, 1st, 2nd, 3rd year labs
Orientador
Imperial College London, Reino Unido

Participação em evento

Descrição da atividade
Tipo de evento
Nome do evento
Instituição / Organização
2018 - Atual EPSRC Panel Member (Physical Sciences)
2018 - Atual BBSRC Panel Member (New Technologies)
2010 - Atual Selected by the RSC Organic Division to present at the EuCheMS symposium in Regensberg

Arbitragem científica em revista

Nome da revista (ISSN) Editora
2016 - Atual Cell Chemical Biology (2451-9456) Elsevier

Comissão de avaliação

Descrição da atividade
Tipo de assessoria
Instituição / Organização Entidade financiadora
2017 - Atual Quinquennial international external review panel, Leiden Institute of Chemistry
Avaliador
2016 - Atual External Examiner, MRes in Drug Discovery, UCL
Avaliador
2016 - Atual Scientific Advisory Board, UCL Alzheimer’s Research UK Drug Discovery Institute
Avaliador
2016 - Atual Habilitation panel, University of Toulouse
Especialista
2016 - Atual Steering Committee, Centre for Agri-tech and Innovation
2015 - Atual Editorial Advisory Board, Molecular BioSystems and Molecular Omics
2013 - Atual Expert Review Panel, Wellcome Trust Strategic Translation Awards
2008 - Atual BBSRC, MRC and EPSRC grants reviewer; member of EPSRC & BBSRC grant panels; reviewer for RSC & ACS journals, JACS, Angew Chemie, Cell, Nature, etc. Recognised as a J. Med. Chem. ‘outstanding reviewer’ in 2012 and 2015
2016 - 2017 External Examiner (Organic Chemistry) for chemistry degree courses at the University of Cardiff
2011 - 2017 COST Action CM1004 “Synthetic Probes for Chemical Proteomics”, management board

Consultoria / Parecer

Descrição da atividade Instituição / Organização
2020 - Atual International advisory board, KU Leuven, Cellular and Molecular Medicine
2019 - Atual Centre for Integrative Biological Signalling Studies, Freiburg, Germany, Scientific Advisory Board
2016 - Atual HEI/Crick joint Research Degrees Committee, and Crick Advisory Group
2013 - Atual External Assessor, MSc in Drug Discovery, University of Surrey
2012 - Atual Editorial Advisory Board member for Biochemical Journal and Journal of Chemical Biology
2011 - Atual RCUK Collaborative Network in Chemical Biology, “Cell Control in a Petri Dish”, management board
2009 - Atual Consultant in chemical biology for FoldRx Pharmaceuticals (US), Pfizer (US/UK), Ono Pharma (Japan), Novartis (Switzerland/US), Wellcome Trust (UK), Summit (UK), Opal Oncology (UK), MISSION Therapeutics (UK), Myricx Pharma (UK)
2008 - 2017 Editorial advisory board, Journal of Chemical Biology (Springer)

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2004 - Atual Lecturer, MSci Chemistry (2nd Year), Biological Chemistry Imperial College London, Reino Unido
2004 - Atual Lecturer, MSci Chemistry (1st year), Cellular Structure
2004 - Atual Lecturer, MRes in Chemical Biology, "Synthetic Chemistry as a Tool for Biology" Imperial College London, Reino Unido

Membro de associação

Nome da associação Tipo de participação
2015 - Atual The Protein Society
2015 - Atual American Society for Biochemistry and Molecular Biology (ASBMB)
2014 - Atual Royal Society of Biology (FRSB)
2014 - Atual Society of Chemical Industry (SCI)
2013 - Atual The American Chemical Society (ACS)
2012 - Atual The Biochemical Society
2006 - Atual Royal Society of Chemistry (FRSC)

Membro de comissão

Descrição da atividade
Tipo de participação
Instituição / Organização
2016 - Atual ICR/Imperial Cancer Research Centre of Excellence (CRCE), Board Member
2008 - 2019 Committee member of the Chemical Biology and Bioorganic Group (Royal Society of Chemistry)
2014 - 2018 Biochemical Society ‘Cells’ panel member

Tutoria

Tópico Nome do aluno
2004 - Atual Organic Chemistry xxxx
Distinções

Prémio

2019 Sir David Cooksey Translation Prize
2015 CRUK Programme Foundation Award
2014 The RSC Norman Heatley Award, Medal and Lecture series in Chemical Biology
2013 The RSC Medimmune Protein and Peptide Science Award
2013 President and Rector’s Award for Excellence in Research Supervision
2012 The Wain Medal and Lecture

Outra distinção

2015 J. Med. Chem. ‘outstanding reviewer’
2012 J. Med. Chem. ‘outstanding reviewer’
2011 Junior Scientist Programme Fellowship